COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 37: Articles 361-370  | Next

Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months Post-COVID-19 Symptom Onset
Samaan, P., Budylowski, P., Russell, V., Srighanthan, J., M. Cheung, A., Ostrowski, M.
10.64898/2026.01.27.701989 — Posted: 2026-01-28
Coupling high-throughput protease enzymology with viral replication reveals biochemical constraints of viral fitness
Aidlen, D., Vo, W. V. T., Young, N. J., Rosecrans, J., Kurianowicz, A., Chuo, S.-W., Asper, G. P. R., Anderson, D., Posner, J. A., Muir, D. F., Freitas, N., Ott, M., Craik, C. S., Taha, T. Y., Pinney, M. M.
10.64898/2026.01.27.702130 — Posted: 2026-01-28
DISCO-LAMP: A Novel discontinuous LAMP assay for isothermal antigen detection
Thomas, B. M., Simeon, R. A., Yan, K. L., Chonira, V., Chen, W. T., Webb, E. L., Mutchler, C., Fernandez, A., Han, J., Chen, Z.
10.64898/2026.01.23.701152 — Posted: 2026-01-28
State-level RN density and age-adjusted covid-19 mortality: Contribution of the nursing workforce to pandemic response
Louis, R., Sakib, S. N., Qinglin, P., Parker, L. A., Morris, J. G.
10.64898/2026.01.25.26343723 — Posted: 2026-01-27
Mass-Standardised IgG Response to Fourteen SARS-CoV-2 Spike Protein variants and Antibody Subclass analysis for IgG subclasses and IgE for a Long COVID Patient Cohort
Elangovan, A., Harper, D., James-Pemberton, P., Kohli, S., Watson, C., Shaw, A.
10.64898/2026.01.26.26344863 — Posted: 2026-01-27
Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies
Weinstein, J. B., Bates, T. A., Anastas, A., Alfahdli, A., Trank-Green, M., McBride, S. K., Garcia, M., Parson, M. A., Jenkins, M. L., Burke, J. E., Barklis, E., Tafesse, F. G.
10.64898/2026.01.26.701894 — Posted: 2026-01-27
The Unexpected Visibility of the SARS-CoV-2 Nucleocapsid Protein Reveals a Hidden Route of Surface Trafficking.
Osuagwu, A., McCausland, J., King, C. L.
10.64898/2026.01.24.701458 — Posted: 2026-01-26
Trophoblast ferroptosis restricts SARS-CoV-2 spread in the placenta
McColl, E., Kumar, D. U., Jones, B., Marks, N., Diveley, E., Karvas, R., Theunissen, T., Kelly, J., Mysorekar, I. U.
10.64898/2026.01.26.701742 — Posted: 2026-01-26
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies
Castro, E., Barre, R., Ye, C., Imbiakha, B., Ezzatpour, S., Cupic, A., Walter, M. R., Kobie, J., Plemper, R. K., Garcia-Sastre, A., Mostafa, A., Aguilar, H., Martinez-Sobrido, L.
10.64898/2026.01.24.700018 — Posted: 2026-01-26
Multifaceted Functional Complexity of SARS-CoV-2 Helicase Nsp13 Underlies Its Integrated Motor and Remodeling Activities
Li, H., Hou, J., Yu, X., Jin, J., Hou, X.-M.
10.64898/2026.01.26.701677 — Posted: 2026-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).